ResearcherKagawa UniversityActive in the last 2 years
Keiko Yamakawa
Matched on OpenAlex author ID A5103646522. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 6
- Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in murine pancreatic cancer. Co-author DOI 10.1038/s41598-025-09445-6↗
- Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in pancreatic cancer. Co-author DOI 10.1016/j.omton.2024.200812↗
- Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice. Co-author DOI 10.1002/eji.202250160↗
- Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.09.006↗
- Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. Co-author DOI 10.1038/s41598-021-86152-y↗
- Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment. Co-author DOI 10.3390/ijms20174224↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Juanjuan Ye · 5 shared papers, 2021–2025 · strength 0.88
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Paper Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice. DOI 10.1002/eji.202250160↗
- Motohiko Kato · 3 shared papers, 2023–2025 · strength 0.66
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Paper Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice. DOI 10.1002/eji.202250160↗
- Naohisa Yahagi · 3 shared papers, 2023–2025 · strength 0.66
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Paper Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice. DOI 10.1002/eji.202250160↗
- Yoko Matsuda · 4 shared papers, 2019–2023 · strength 0.54
- Paper Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice. DOI 10.1002/eji.202250160↗
- Paper Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment. DOI 10.3390/ijms20174224↗
- Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
- Akira Nishiyama · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Kyuichi Kadota · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Masanao Yokohira · 3 shared papers, 2019–2021 · strength 0.34
- Paper Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment. DOI 10.3390/ijms20174224↗
- Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
- Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
- Motohiro Kojima · 2 shared papers, 2021 · strength 0.22
- Yasuyuki Suzuki · 2 shared papers, 2021 · strength 0.22
- Keiichi Okano · 2 shared papers, 2021 · strength 0.22
- Minoru Oshima · 1 shared paper, 2021 · strength 0.12
- Kenichi Hirabayashi · 1 shared paper, 2021 · strength 0.12
- Ai Kameyama · 1 shared paper, 2021 · strength 0.10
- Ayaka Shimomura · 1 shared paper, 2021 · strength 0.10
- Mutsuo Furihata · 1 shared paper, 2021 · strength 0.10
- Mari A. Mino-Kenudson · 1 shared paper, 2021 · strength 0.10
- Chiharu Tanaka · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.